Ernexa Therapeutics Announces Participation in the D. Boral Capital Inaugural Global Conference
Ernexa Therapeutics (NASDAQ: ERNA) has announced its participation in the upcoming D. Boral Capital Inaugural Global Conference, scheduled for May 14, 2025, at The Plaza Hotel in New York City. The company's President & CEO, Sanjeev Luther, will be available for one-on-one meetings with interested parties from 9:00 A.M. to 3:00 P.M. (ET). Attendees wishing to schedule meetings can contact John Perez at [email protected].
Ernexa Therapeutics (NASDAQ: ERNA) ha annunciato la sua partecipazione al prossimo D. Boral Capital Inaugural Global Conference, previsto per il 14 maggio 2025 presso il The Plaza Hotel di New York City. Il Presidente e CEO della societ脿, Sanjeev Luther, sar脿 disponibile per incontri individuali con le parti interessate dalle 9:00 alle 15:00 (ET). I partecipanti che desiderano fissare un appuntamento possono contattare John Perez all'indirizzo [email protected].
Ernexa Therapeutics (NASDAQ: ERNA) ha anunciado su participaci贸n en la pr贸xima D. Boral Capital Inaugural Global Conference, programada para el 14 de mayo de 2025 en The Plaza Hotel en la ciudad de Nueva York. El Presidente y CEO de la compa帽铆a, Sanjeev Luther, estar谩 disponible para reuniones individuales con interesados desde las 9:00 a.m. hasta las 3:00 p.m. (ET). Los asistentes que deseen agendar reuniones pueden contactar a John Perez en [email protected].
Ernexa Therapeutics (NASDAQ: ERNA)电� 2025雲� 5鞗� 14鞚� 雺挫殨 鞁� 頂岆澕鞛� 順疙厰鞐愳劀 鞐措Μ电� D. Boral Capital Inaugural Global Conference鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 靷灔 瓴� CEO鞚� Sanjeev Luther电� 鞓れ爠 9鞁滊秬韯� 鞓ろ泟 3鞁�(霃欕秬 鞁滉皠)旯岇 甏�鞁� 鞛埖鐢 攵勲摛瓿� 鞚茧寑鞚� 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 氙疙寘 鞓堨暯鞚� 鞗愴晿电� 彀胳劃鞛惖鐢 John Perez鞐愱矊 [email protected]鞙茧 鞐半澖頃� 靾� 鞛堨姷雼堧嫟.
Ernexa Therapeutics (NASDAQ : ERNA) a annonc茅 sa participation 脿 la prochaine D. Boral Capital Inaugural Global Conference, pr茅vue le 14 mai 2025 au The Plaza Hotel 脿 New York. Le pr茅sident-directeur g茅n茅ral de la soci茅t茅, Sanjeev Luther, sera disponible pour des r茅unions individuelles avec les parties int茅ress茅es de 9h00 脿 15h00 (heure de l'Est). Les participants souhaitant planifier des rendez-vous peuvent contacter John Perez 脿 [email protected].
Ernexa Therapeutics (NASDAQ: ERNA) hat seine Teilnahme an der bevorstehenden D. Boral Capital Inaugural Global Conference angek眉ndigt, die am 14. Mai 2025 im The Plaza Hotel in New York City stattfindet. Der Pr盲sident und CEO des Unternehmens, Sanjeev Luther, steht von 9:00 bis 15:00 Uhr (ET) f眉r Einzelgespr盲che mit Interessenten zur Verf眉gung. Teilnehmer, die Termine vereinbaren m枚chten, k枚nnen John Perez unter [email protected] kontaktieren.
- None.
- None.
Cambridge, Massachusetts--(Newsfile Corp. - May 8, 2025) - Ernexa Therapeutics (NASDAQ: ERNA), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.
Sanjeev Luther, President & CEO, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. (ET).
To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at [email protected].
About Ernexa Therapeutics
About Ernexa TherapeuticsErnexa Therapeutics (NASDAQ: ERNA) is developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune disease. Ernexa’s core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa’s allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment solution, without needing patient-specific cell harvesting.
Ernexa is developing two highly innovative cell therapy products, both currently in preclinical stages. ERNA-101 is the company’s lead cell therapy product, designed to activate and regulate the immune system’s response to recognize and attack cancer cells. ERNA-102 is a cell therapy product designed to target inflammation and treat autoimmune disease. The company’s initial focus is to develop ERNA-101 for the treatment of ovarian cancer.
For more information, visit .
About D. Boral Capital
D. Boral Capital LLC is an investment bank headquartered in New York which provides advisory and financing solutions to middle market and emerging growth companies. The Company has a proven track record of offering strategic guidance to clients across the globe in any sector, with access to capital from the USA, Asia, Europe, Middle East, and Latin America.
D. Boral Capital is a leader on Wall Street, having aggregated over
For further information:
Ernexa Therapeutics
Sharon Golubchik
6094180058
[email protected]
Source Ernexa Therapeutics
FAQ
When is Ernexa Therapeutics (ERNA) participating in the D. Boral Capital Conference?
Who will represent Ernexa Therapeutics (ERNA) at the D. Boral Capital Conference?
What are the meeting hours for Ernexa Therapeutics (ERNA) at the D. Boral Capital Conference?
How can investors schedule meetings with Ernexa Therapeutics (ERNA) management at the conference?
